MEDLY CONNECT Trademark

Trademark Overview


On Wednesday, January 5, 2022, a trademark application was filed for MEDLY CONNECT with the United States Patent and Trademark Office. The USPTO has given the MEDLY CONNECT trademark a serial number of 97203894. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 27, 2023. This trademark is owned by Medly Health Inc.. The MEDLY CONNECT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing non-downloadable, namely, software as a service (SaaS) featuring a web based application with personal login/verification; providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services enabling the sale and purchase of prescription medicines via a global computer network providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services providing prescription orders via a global communication network; providing non-downloadable, namely, providing software as a service (SaaS) featuring website enabling the purchase of prescription medicine via a global computer network; providing software as a service (SaaS) featuring on-line retail store services featuring prescription medicine; providing use of non-downloadable software, namely, software as a service (SaaS) featuring pharmaceutical consultation; providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services, namely, proce...
medly connect

General Information


Serial Number97203894
Word MarkMEDLY CONNECT
Filing DateWednesday, January 5, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, April 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkMEDLEY CONNECT
Goods and Servicesproviding non-downloadable, namely, software as a service (SaaS) featuring a web based application with personal login/verification; providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services enabling the sale and purchase of prescription medicines via a global computer network providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services providing prescription orders via a global communication network; providing non-downloadable, namely, providing software as a service (SaaS) featuring website enabling the purchase of prescription medicine via a global computer network; providing software as a service (SaaS) featuring on-line retail store services featuring prescription medicine; providing use of non-downloadable software, namely, software as a service (SaaS) featuring pharmaceutical consultation; providing non-downloadable, namely, software as a service (SaaS) featuring pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; providing non-downloadable, namely, software as a service (SaaS) featuring retail store services for prescription drugs; providing non-downloadable, namely, software as a service (SaaS) featuring retail store services, namely, pharmacy, retail drug store, medicine, and medical merchandise store services; providing non-downloadable software, namely, software as a service (SaaS) featuring pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies for customers, including hospitals, physicians, medical staff, professionals, and patients; providing use of non-downloadable software for administering pharmacy reimbursement programs; software as a service (SaaS) services, namely, providing non-downloadable computer software and applications for drug and pharmaceutical inventory management, tracking, managing, and reporting of information in connection with Federal 340B pharmacy programs and discount prescription drug programs for eligible organizations and pharmacies to allow them to offer drug distribution services on behalf of covered entities in compliance with the Federal 340B pharmacy programs, and discount prescription drug programs; non-downloadable computer software enabling the sale and purchase of prescription medicines via a global computer network; providing a website enabling the purchase of prescription medicine via a global computer network; providing non-downloadable software featuring a communication platform via a global communication network; non-downloadable computer software enabling access to a computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedly Health Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrooklyn, NY 11206

Trademark Events


Event DateEvent Description
Thursday, April 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, April 27, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, April 27, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022NON-FINAL ACTION E-MAILED
Thursday, October 13, 2022NON-FINAL ACTION WRITTEN
Tuesday, October 11, 2022ASSIGNED TO EXAMINER
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 13, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 8, 2022NEW APPLICATION ENTERED